GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » Hemas Holdings PLC (COL:HHL.N0000) » Definitions » Valuation Rank

Hemas Holdings (COL:HHL.N0000) Valuation Rank


View and export this data going back to 2003. Start your Free Trial

What is Hemas Holdings Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Hemas Holdings Valuation Rank Related Terms

Thank you for viewing the detailed overview of Hemas Holdings's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Hemas Holdings (COL:HHL.N0000) Business Description

Traded in Other Exchanges
N/A
Address
No. 75, Braybrooke Place, Hemas House, Colombo, LKA, 02
Hemas Holdings PLC holds investments in companies with diversified businesses in Sri Lanka. Its businesses include manufacturing, trading and distributing FMCG products, pharmaceutical products, healthcare products, provision of medical care, operating tourism business, hotel management, airlines, shipping business, IT solutions, among others. It has the following reportable segments: Consumer, Healthcare, Leisure, Travel & Aviation, Mobility, and Other segments. The healthcare segment which generates majority revenue distributes pharmaceuticals, surgical and diagnostics products, and owns and manages hospitals.